Cephalon, Inc. - UPI.com

Home
Top News
Entertainment
Odd News
Sports
- Baseball
- Football
- Golf
- Olympics 2008
Business
Science
Health
Analysis
Video
News Photos

Cephalon, Inc. Add to My Watchlist

(NSDQ: CEPH)

Detailed Quote

Last Price	76.96 ( 5:20 PM EDT)
Change (%)	-0.21 (-0.27%)
Volume	731,646
Open	77.10
Previous Close	77.17
Day High	77.13
Day Low	76.12
Bid	72.50 x 100
Ask	77.45 x 100

Average Volume	1,386,430
Shares Outstanding	67.74M
Market Cap	5.2B
Year High	79.10
Year Low	56.20
Earnings Per Share	-2.59
P/E Ratio	-
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)
DNA	97.43	-0.56 (-0.57%)
AMGN	63.81	+0.24 (+0.38%)
GILD	54.15	-0.47 (-0.86%)
CELG	71.91	-0.43 (-0.59%)
GENZ	79.89	-1.40 (-1.72%)
CMXHF	32.40	-0.20 (-0.61%)
BIIB	53.16	-0.94 (-1.74%)

Tue, Aug 12, 2008
	Zacks Analyst Blog Highlights: Comerica Inc., Advance Auto Parts, Inc., Eurand N.V., Cephalon Inc. and GlaxoSmithKline Plc. - Business Wire
Thu, Aug 07, 2008
	Wall Street News Alert Issues Special Alert on UNDT! August 7, 2008 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. - MarketWire
Tue, Jul 29, 2008
	Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 - PR Newswire
Thu, Jul 17, 2008
	Wall Street News Alert: Breaking News Alert - OCOL! July 17, 2008 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. - MarketWire
	Zacks Bull and Bear of the Day Highlights: Canadian Solar, Corp. Executive Board, UDR, Cephalon and ASML Holding - Business Wire
More Press Releases

Mon, Aug 18, 2008
	Five Cash Flow Kings For August 18 (SLE) Cash flow analysis can put the fortunes of a company into an entirely new light. This week features Sara Lee. - Investopedia
Mon, Aug 04, 2008
	Five Stocks That Are Defying Market Conditions (TYC, AZN, CEPH) Not all companies are missing earnings - some are even beating earnings and raising guidance. - Investopedia
Fri, Aug 01, 2008
	The Next Stocks You Should Buy It's time to think about the future. - Fool.com Headlines
Wed, Jul 30, 2008
	Cephalon, Inc. Q2 2008 Earnings Call Cephalon, Inc. (CEPH) Q2 FY08 Earnings Call Complete Story » - Transcripts from See...
Fri, Jul 25, 2008
	Time to Get Greedy Don't let this opportunity pass you by. - Fool.com Headlines
More News

Fri, Aug 15, 2008
	Institutional Money Flocking in Biotech One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a traditional[More...] - home: iStockAnalyst....
	Where is Institutional Money Flocking? Biotech - 3 ETFs to Review - Fund my Mutual Fund
	Where is Institutional Money Flocking? Biotech - 3 ETFs to Review - Fund my Mutual Fund
Tue, Aug 12, 2008
	FDA warns about Alkermes-Cephalon alcoholism drug A drug to treat alcoholism developed by Alkermes Inc. has caused blood clots, swelling, abscesses, cell death and other adverse reactions in nearly 200 cases, according to a warning for health-care professionals issued Tuesday by the Food and Drug Administration. (ALKS) (CEPH) - Philadelphia Busines...
Mon, Aug 11, 2008
	Analyst Comments: Corrections Corp, Alnylam Pharma, Ryland, Eurand Pharma, HCP Corrections Corporation of America (CXW) holds a significant market share advantage over its peers, with a substantial pipeline of additional capacity scheduled to be added to the portfolio over the next two years. CXW is the clear leader in an industry with a strong outlook, supported by favorable economic and demographic trends. Shares of CXW trade at 21.2x and 17.2x our 2008 and 2009 EPS estimates, respectively. The multiples represent a premium to peer group average multiples of 17.3x and 14.4x consensus 2008 and 2009 EPS estimates, respectively. We note, however, that the consensus estimates for one competitor have yet to be updated after the release of a disappointing full-year outlook and subsequent 17% sell-off in the shares. Additionally, shares of CXW are currently trading at approximately 10.9x and 9.1x our 2008 and 2009 EBITDA estimates, respectively. Only 7% of[More...] - home: iStockAnalyst....
More Blogs

Fri, May 02, 2008
	Market Recap: Nonfarm Payrolls Fall Less Than Expected; Cephalon and Research in Motion in Focus Schaeffer's Colleen King takes a look at activity on the Street after the market close - Schaeffer's
Wed, Feb 13, 2008
	Market Recap: Stocks Climb on Retail Strength Beth Gaston Moon takes a look back at news driving the market today. - Schaeffer's
More Podcasts

07/29/08		Q2 2008 Earnings Archive for CEPH
05/14/08		Special Conference Cephalon, Inc. at Banc of America Securities Health Care Conference Archive for CEPH
05/06/08		Business News Cephalon to discuss the U.S. Food and Drug Administration advisory committee panel meeting Archive for CEPH
05/01/08		Q1 2008 Earnings Archive for CEPH
03/19/08		Special Conference Cephalon, Inc. at Lehman Brothers Healthcare Conference Archive for CEPH

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
NYMEX & COMEX data is delayed at least 30 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs